HealthTech Arva Health Launches At-Home Fertility Test for Women with PCOS and Thyroid Issues

• ByStartupStory     |    December 15, 2023

Bengaluru-based startup Arva Health is revolutionizing women’s healthcare with the introduction of an at-home fertility test designed to empower women with data-driven insights. Developed in collaboration with top fertility specialists, the test allows women to monitor and track up to 12 hormone levels affecting fertility from the comfort of their homes. The initiative aims to provide affordable fertility testing, particularly catering to Indian women dealing with conditions such as Polycystic Ovary Syndrome (PCOS) and thyroid issues.

Founder of Arva Health, Nidhi Panchmal, expressed the company’s commitment to addressing the long-overlooked aspect of women’s health in India. “At Arva Health, we believe that every woman deserves to know her body, and we are committed to empowering women to make informed decisions about their reproductive future,” she said.

The Arva Fertility Test is positioned as a powerful tool to help women detect fertility issues early on, allowing them to take control of their reproductive journey. The test’s affordability compared to traditional infertility clinics and its focus on privacy underscore Arva Health’s dedication to making reproductive health more accessible.

Dipalie Bajaj, Co-Founder and CEO of Arva Health, highlighted the company’s broader vision, stating, “We aim to be a reproductive health concierge, helping users manage their health journey by recommending safe, vetted doctors, facilitating appointment bookings, and connecting users with a supportive community of individuals on a similar path.”

Arva Health recognizes the growing trend of women choosing to have children later in life, emphasizing the need for better understanding and management of reproductive health. The startup’s digital platform provides more than just diagnostic results; it offers personalized insights based on individual data, helping women comprehend the influence of lifestyle choices on fertility health.

The at-home fertility test covers often-overlooked tests like Anti-Mullerian Hormone (AMH) and Ovarian Reserve, offering comprehensive insights into the biological clock and the impact of conditions like PCOS on fertility. Arva Health’s commitment goes beyond diagnostics, providing a holistic approach to understanding reproductive health and identifying potential issues for proactive measures.

The startup, founded in early 2023, has partnered with trusted labs for at-home blood and sample collection, ensuring privacy and convenience for users. Arva Health shares detailed fertility reports within 48 hours, aiming to be a guiding force in women’s reproductive health.

“Arva Health’s At-Home Fertility Test for Women offers an unprecedented opportunity for women to understand their reproductive hormones in clear and straightforward language,” the company stated. “It includes often-overlooked tests like AMH and Ovarian Reserve, and the reports offer personalized insights based on individual data, helping women understand how their lifestyle choices influence fertility health.”

Follow Startup Story